Cytokinetics Inc. (CYTK)

$ 66.98
   
  • Change Today:
    $0.36
  • 52 Week High: $67.67
  • 52 Week Low: $66.01
  • Currency: US Dollars
  • Shares Issued: 55.37m
  • Volume: 1,569,649
  • Market Cap: $3,708.89m
  • RiskGrade: 332
  • Beta: 0.04

CYTK Overview

1 Day Chart (18-02-2026)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

CYTK Fundamentals

Fundamentals data is not available for this company.

CYTK Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 118.71 (706.91) (515.21)¢ n/a n/a n/a n/a 0.0%
31-Dec-27 373.70 (522.78) (370.17)¢ n/a n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

CYTK ShareCast News

No recent information was found.

CYTK Top Newspaper Links

Amgen picks up new heart drug 28-May-2009 Chicago Tribune
Amgen pays $50 million for rights to heart drug 27-May-2009 LA Times
A Tough Quarter for Some Drug Makers 26-Jan-2007 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

CYTK Market Data

Currency US Dollars
Share Price $ 66.98
Change Today $ 0.36
% Change 0.54 %
52 Week High $67.67
52 Week Low $66.01
Volume 1,569,649
Shares Issued 55.37m
Market Cap $3,708.89m
Beta 0.04
RiskGrade 332

What The Brokers Say

Strong Buy 3
Buy 13
Neutral 4
Sell 0
Strong Sell 0
Total 20
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page